Business profile & competitive position
Hormel Foods Corporation operates in the Consumer Defensive sector under the Packaged Foods industry. The company’s core business is manufacturing and marketing branded shelf-stable and refrigerated foods, with a long-recognized focus on protein-centric products such as canned meats, deli meats, nut butters and refrigerated prepared foods. These categories sit in the non-discretionary part of the grocery basket, so demand is usually more stable than cyclical industries.
What the current profitability figures say about the competitive moat, however, is more measured. Hormel carries a net margin of 3.8% and a return on equity of 5.9%. In a packaged-foods context, mid-single-digit net margins are not unusual for large protein-heavy portfolios, but they are also not the profile of a pricing-power leader. Low ROE relative to many peers suggests assets are not generating especially high returns for shareholders right now. That combination implies a business whose moat rests largely on brand recognition, scale distribution and low consumer price elasticity rather than on exceptional margin expansion. The beta of 0.33 confirms that the stock historically swings far less than the overall market, which is consistent with a defensive, mature consumer-staples name where volatility is dampened by steady demand rather than rapid growth.
Financial posture
Hormel’s financial snapshot puts it at a market capitalization of $13.8 billion, a trailing P/E ratio of 29.4, the above-mentioned 3.8% net margin and 5.9% ROE. The P/E is the figure that most clearly separates the valuation story from the profitability story: a multiple near 29x is relatively steep for a company producing sub-6% ROE and sub-4% net margins. That gap typically means the market is looking through current earnings toward some combination of brand stability, future margin repair, or capital discipline rather than pricing the stock purely on current returns.
The stock is currently trading at $25.02, just above the 50-day EMA of $24.53, and the RSI is 49.6 — essentially neutral territory. Those technical readings do not point to an overbought or oversold condition heading into the next quarterly release. With the beta at 0.33, investors generally expect day-to-day moves to be muted compared with the broad market, although that tendency does not prevent larger single-day earnings reactions.
Macro & geopolitical exposure
As a Packaged Foods company in the Consumer Defensive sector, Hormel’s exposures cluster around four macro themes rather than broad economic cyclicality.
First, input-cost volatility: pork, turkey, peanuts, other proteins and packaging are major cost drivers. When commodity prices rise, margin compression can be quick unless the company passes them through to retailers and consumers.
Second, regulatory and food-safety oversight: packaged protein is heavily regulated by the USDA, FDA and state agencies. New labeling, animal-welfare or environmental rules can change cost structures across the industry.
Third, currency and trade policy: because packaged-foods giants operate in many countries, foreign-exchange swings and tariffs on agricultural products can move reported results and strategic value of overseas assets.
Fourth, consumer behavior in inflationary periods: even within defensive staples, shoppers may trade down to private-label products or switch proteins, which can pressure volume and mix. The Brazil divestiture highlighted in recent news underscores how global footprint management matters for Hormel’s portfolio. These exposures are inherent to the industry classification and are why packaged-foods names are often described as “stable but not immune.”
Recent developments
Recent headlines have been quiet but informative. On August 4, 2026, DefenceWorld.net reported that Amundi increased its position in Hormel Foods Corporation, showing that at least one major European asset manager saw incremental value around current levels. On August 3, 2026, Hormel announced its upcoming third quarter earnings call in a PR Newswire release, and the same day DefenceWorld.net noted that brokerages had given the stock a consensus “Hold” recommendation. That Hold rating is a useful snapshot of where the sell-side stands: not bearish enough to recommend selling, but not bullish enough to recommend buying aggressively.
Earlier, on July 31, 2026, GuruFocus.com reported that Hormel Foods completed the sale of its CERATTI® business in Brazil. Divestitures of non-core international assets can sharpen management focus and simplify capital allocation, though they can also signal that those markets were underperforming corporate-return hurdles. Taken together, these items frame a company in portfolio-cleanup mode rather than one pursuing a major expansion narrative.
Earnings behavior & post-earnings drift
Hormel’s earnings track record over the last eight reported quarters shows a beat rate of 5 out of 8, or 62%, with an average earnings surprise of just 1%. The striking part is not the frequency of beats but what happens after the report. The average 5-day price move following earnings across those quarters is -0.98%, classified as a downward drift. In other words, the stock has on average given back ground after the announcement.
The last four quarters make that pattern concrete:
- May 28, 2026: EPS of $0.40 beat the estimate of $0.3544 by 12.9%. The stock fell 1.53% the next day and -1.27% over the following five days.
- February 26, 2026: EPS of $0.34 beat the estimate of $0.32 by 6.3%. The stock jumped 3.14% the next day but then drifted -2.54% over the next five days.
- December 4, 2025: EPS of $0.32 beat the estimate of $0.3017 by 6.1%. The stock rose 0.75% the next day and then slid -1.86% over the following five days.
- August 28, 2025: EPS of $0.35 missed the estimate of $0.4015 by -12.8%. Despite the miss, the stock rose 0.87% the next day and 1.74% over the next five days.
This is the key takeaway for earnings-oriented traders: Hormel has shown a disconnect between the quarterly result and the intermediate price direction. Beats have sometimes produced an initial pop but rarely held over five sessions, and the largest miss in this window was actually followed by a short-term gain. That behavior suggests the market’s real expectation may be priced in well before the release, and that forward guidance, valuation reset, or sector rotation can override the headline surprise.
The next event is scheduled for August 27, 2026, before the market open, with a consensus EPS estimate of $0.353. Whether that number is beaten or missed, the historical record suggests the post-earnings reaction may be as much about tone and guidance as it is about the raw EPS print. For readers who want to go further, the full institutional verdict is worth reviewing as a deeper dive into how analysts, fund managers and risk models are positioned around this name.
Frequently Asked Questions
What does Hormel’s 5.9% ROE say about its competitive strength?
A 5.9% ROE is on the low side for a large consumer staples company. It suggests Hormel’s asset base is generating only modest shareholder returns, which is consistent with a business facing cost pressures and pricing constraints typical of packaged proteins. Brand strength may provide stability, but the numbers do not currently point to a deep, high-return moat.
Why does HRL often drift lower even after beating earnings?
Over the last eight quarters, HRL has beaten 62% of the time but averaged a -0.98% five-day post-earnings drift. Recent beats in February, December and May 2026 each saw the stock give back initial gains within five sessions. This pattern suggests expectations are often set ahead of the report, and the stock focuses more on guidance, valuation or sector flows than on the headline beat.
What is the next earnings date and consensus estimate for HRL?
Hormel is scheduled to report on August 27, 2026, before the market open. The current consensus EPS estimate is $0.353, which is roughly in line with where estimates have been for recent quarters.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-05-28 | $0.4 | $0.3544 | +12.9% | -1.53% | -1.27% |
| 2026-02-26 | $0.34 | $0.32 | +6.3% | +3.14% | -2.54% |
| 2025-12-04 | $0.32 | $0.3017 | +6.1% | +0.75% | -1.86% |
| 2025-08-28 | $0.35 | $0.4015 | -12.8% | +0.87% | +1.74% |
| 2025-05-29 | $0.35 | $0.3417 | +2.4% | - | - |
| 2025-02-27 | $0.35 | $0.3764 | -7% | - | - |
Previous HRL editions
Get the institutional verdict on HRL
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the HRL verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.